ASHLEY HEIMERMAN: Open Payments
NPI 1629620117 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$160 in 8 payments from 6 companies in 2025. Trend: 2023 $71 · 2024 $168 · 2025 $160
Food & beverage: $160
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 2 | $41 |
| Insulet Corporation | 2 | $37 |
| Dexcom, Inc. | 1 | $29 |
| Tandem Diabetes Care, Inc. | 1 | $18 |
| Xeris Pharmaceuticals, Inc. | 1 | $18 |
| ABBVIE INC. | 1 | $17 |
Products named: CRENESSITY, Omnipod, Dexcom G6 Transmitter, t:slim X2 Insulin Pump with Control-IQ, GVOKE HYPOPEN, LUPRON DEPOT.
Industry payments across MO — which companies pay providers there.
